These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
399 related articles for article (PubMed ID: 18204222)
1. Single nucleotide polymorphisms in nucleotide excision repair genes XPA, XPD, XPG and ERCC1 in advanced colorectal cancer patients treated with first-line oxaliplatin/fluoropyrimidine. Monzo M; Moreno I; Navarro A; Ibeas R; Artells R; Gel B; Martinez F; Moreno J; Hernandez R; Navarro-Vigo M Oncology; 2007; 72(5-6):364-70. PubMed ID: 18204222 [TBL] [Abstract][Full Text] [Related]
2. DNA repair genes XPC, XPG polymorphisms: relation to the risk of colorectal carcinoma and therapeutic outcome with Oxaliplatin-based adjuvant chemotherapy. Liu D; Wu HZ; Zhang YN; Kang H; Sun MJ; Wang EH; Yang XL; Lian MQ; Yu ZJ; Zhao L; Olopade OI; Wei MJ Mol Carcinog; 2012 Oct; 51 Suppl 1():E83-93. PubMed ID: 22213216 [TBL] [Abstract][Full Text] [Related]
4. The combination of ERCC1 and XRCC1 gene polymorphisms better predicts clinical outcome to oxaliplatin-based chemotherapy in metastatic colorectal cancer. Liang J; Jiang T; Yao RY; Liu ZM; Lv HY; Qi WW Cancer Chemother Pharmacol; 2010 Aug; 66(3):493-500. PubMed ID: 19960344 [TBL] [Abstract][Full Text] [Related]
5. A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer. Park DJ; Stoehlmacher J; Zhang W; Tsao-Wei DD; Groshen S; Lenz HJ Cancer Res; 2001 Dec; 61(24):8654-8. PubMed ID: 11751380 [TBL] [Abstract][Full Text] [Related]
6. A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer. Stoehlmacher J; Park DJ; Zhang W; Yang D; Groshen S; Zahedy S; Lenz HJ Br J Cancer; 2004 Jul; 91(2):344-54. PubMed ID: 15213713 [TBL] [Abstract][Full Text] [Related]
7. Laryngeal cancer risk and common single nucleotide polymorphisms in nucleotide excision repair pathway genes ERCC1, ERCC2, ERCC3, ERCC4, ERCC5 and XPA. Lu B; Li J; Gao Q; Yu W; Yang Q; Li X Gene; 2014 May; 542(1):64-8. PubMed ID: 24582975 [TBL] [Abstract][Full Text] [Related]
8. Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy. Ryu JS; Hong YC; Han HS; Lee JE; Kim S; Park YM; Kim YC; Hwang TS Lung Cancer; 2004 Jun; 44(3):311-6. PubMed ID: 15140544 [TBL] [Abstract][Full Text] [Related]
9. Predictive Value of Single Nucleotide Polymorphisms of ERCC1, XPA, XPC, XPD and XPG Genes, Involved in NER Mechanism in Patients with Advanced NSCLC Treated with Cisplatin and Gemcitabine. Mlak R; Krawczyk P; Homa-Mlak I; Powrózek T; Ciesielka M; Kozioł P; Milanowski J; Małecka-Massalska T Pathol Oncol Res; 2019 Jul; 25(3):1035-1045. PubMed ID: 30066234 [TBL] [Abstract][Full Text] [Related]
10. ERCC1 codon 118 polymorphism is a predictive factor for the tumor response to oxaliplatin/5-fluorouracil combination chemotherapy in patients with advanced colorectal cancer. Viguier J; Boige V; Miquel C; Pocard M; Giraudeau B; Sabourin JC; Ducreux M; Sarasin A; Praz F Clin Cancer Res; 2005 Sep; 11(17):6212-7. PubMed ID: 16144923 [TBL] [Abstract][Full Text] [Related]
11. ERCC1 and XPD/ERCC2 polymorphisms' predictive value of oxaliplatin-based chemotherapies in advanced colorectal cancer has an ethnic discrepancy: a meta-analysis. Lu X; Xiao S; Jin C; van der Straaten T; Li X J Clin Lab Anal; 2012 Jan; 26(1):10-5. PubMed ID: 24833529 [TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in nucleotide excision repair genes and susceptibility to colorectal cancer in the Polish population. Paszkowska-Szczur K; Scott RJ; Górski B; Cybulski C; Kurzawski G; Dymerska D; Gupta S; van de Wetering T; Masojć B; Kashyap A; Gapska P; Gromowski T; Kładny J; Lubiński J; Dębniak T Mol Biol Rep; 2015 Mar; 42(3):755-64. PubMed ID: 25391773 [TBL] [Abstract][Full Text] [Related]
13. [Relationship between single nucleotide polymorphism in repair gene XPD751 and prognosis in colorectal carcinoma patients]. Chen YM; Wu XL; Zhang LW; Xu X; Liu JW Zhonghua Zhong Liu Za Zhi; 2012 Jul; 34(7):501-5. PubMed ID: 22967467 [TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms of the XPG and XPD nucleotide excision repair genes in sarcoma patients. Le Morvan V; Longy M; Bonaïti-Pellié C; Bui B; Houédé N; Coindre JM; Robert J; Pourquier P Int J Cancer; 2006 Oct; 119(7):1732-5. PubMed ID: 16646069 [TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetic approach for capecitabine or 5-fluorouracil selection to be combined with oxaliplatin as first-line chemotherapy in advanced colorectal cancer. Martinez-Balibrea E; Abad A; Aranda E; Sastre J; Manzano JL; Díaz-Rubio E; Gómez-España A; Aparicio J; García T; Maestu I; Martínez-Cardús A; Ginés A; Guino E; Eur J Cancer; 2008 Jun; 44(9):1229-37. PubMed ID: 18448328 [TBL] [Abstract][Full Text] [Related]
16. Association between polymorphisms of ERCC1 and XPD and clinical response to platinum-based chemotherapy in advanced non-small cell lung cancer. Li F; Sun X; Sun N; Qin S; Cheng H; Feng J; Chen B; Cheng L; Lu Z; Ji J; Zhou Y Am J Clin Oncol; 2010 Oct; 33(5):489-94. PubMed ID: 20351547 [TBL] [Abstract][Full Text] [Related]
17. Polymorphisms of nucleotide-excision repair genes may contribute to sperm DNA fragmentation and male infertility. Gu A; Ji G; Zhou Y; Long Y; Shi X; Fu G; Wang S; Song L; Wang X Reprod Biomed Online; 2010 Nov; 21(5):602-9. PubMed ID: 20864414 [TBL] [Abstract][Full Text] [Related]